Bolus application of a novel recombinant plasminogen activator in acute myocardial infarction patients: pharmacokinetics and effects on the hemostatic system.
Seifried
E
E
Department of Internal Medicine, University of Ulm, Donau, Germany.
Müller
M M
MM
Martin
U
U
König
R
R
Hombach
V
V
D000328:Adult; D000368:Aged; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D006207:Half-Life; D006490:Hemostatics; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology
D005343:Fibrinolytic Agents; D006490:Hemostatics; D011994:Recombinant Proteins; C087896:reteplase; D010959:Tissue Plasminogen Activator